Pralatrexate price?

Pralatrexate (brand: Folotyn®)

| Region | Typical Cost (per month) | Notes |
|--------|--------------------------|-------|
| United States | ≈ $20 000 – $30 000 (average wholesale price) | Actual out‑of‑pocket cost varies widely with insurance, copays, and manufacturer discount programs. In many cases, the drug is covered by specialty‑drug formularies and the manufacturer’s patient‑assistance program can lower costs considerably. |
| Canada | ≈ CAD $25 000 – $35 000 | Prices are often similar to the U.S. wholesale rate; provincial drug plans negotiate rebates. |
| United Kingdom | ≈ £12 000 – £16 000 | NHS contracts and patient‑access schemes can reduce the final charge. |
| Australia | ≈ AUD $25 000 – $35 000 | Public hospital procurement and private insurance impact the final price. |

Key Take‑aways

1. High‑cost oncology drug – pralatrexate is a specialty anti‑cancer agent and its price reflects the manufacturing complexity, limited patient population, and the fact that it is a brand‑name drug.
2. Insurance & rebates – Most patients receive the drug through specialty pharmacy networks that negotiate rebates with the manufacturer, which can lower the net cost to the payer.
3. Patient assistance – The manufacturer offers a “Patient Assistance Program” that can provide the medication free of charge (or at a discounted rate) to eligible patients who cannot afford it.
4. Pricing changes – Drug prices are subject to change due to new patent filings, generic entry, or price‑reform negotiations. Always check with your pharmacy or payer for the most up‑to‑date cost information.

If you’re looking for a more precise figure for your specific situation, it’s best to consult the pharmacy that will dispense the drug or contact the manufacturer’s patient‑assistance department.